← Eichor
Study identifier: NCT05807854 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

RSA Vs RCR for Massive RCTs

Condition: Rotator Cuff Tears  ·  Sponsor: La Tour Hospital

PhaseNA
Planned participants160
Who can joinAll sexes, 60 Years to 80 Years
Healthy volunteersNo

About this study

Different treatment options are available for massive or irreparable rotator cuff tears. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved. However, the healing rate of massive rotator cuff tears after repair may remain low and failure of healing is associated with progression of arthritis. An alternative to arthroscopic or open repair is reverse shoulder arthroplasty which decreases pain and improves function, active shoulder elevation and quality of life. The primary goal of this prospective multicentric randomized study is to determine if there is a difference of functional outcomes between rotator cuff repair (RCR) repair and reverse shoulder arthroplasty (RSA).

This description comes directly from the study's public registry record.

Talk to the study team

Alexandre Lädermann, MD  ·  +41 22 71 975 55  ·  alexandre.laedermann@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Oregon Health & Science UniversityPortland, Oregon, United StatesRecruiting
La Tour hospitalMeyrin, Canton of Geneva, SwitzerlandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05807854